Bellicum Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Bellicum Pharmaceuticals Inc
CIK #0001358403
EDGAR Form CIK 2011 - 2026
10-K [0001358403]
10-Q [0001358403]
3 [0001358403]
4 [0001358403]
8-K [0001358403]
D [0001358403]
SC 13D [0001358403]
SC 13G [0001358403]
Form 13D/13G Filer Form 13D/13G Subject Filed
Armistice Capital LLC Bellicum Pharmaceuticals Inc [2025-08-14]
Baker Bros Advisors LP Bellicum Pharmaceuticals Inc [2023-05-05]
Bellicum Pharmaceuticals Inc Bellicum Pharmaceuticals Inc [2022-11-18]
Vanguard Group Inc Bellicum Pharmaceuticals Inc [2022-02-09]
Armistice Capital LLC Bellicum Pharmaceuticals Inc [2021-02-16]
Ikarian Capital LLC Bellicum Pharmaceuticals Inc [2021-01-11]
Renaissance Technologies LLC Bellicum Pharmaceuticals Inc [2020-02-12]
Armistice Capital LLC Bellicum Pharmaceuticals Inc [2019-08-26]
Boxer Capital LLC Bellicum Pharmaceuticals Inc [2019-08-26]
Baker Bros Advisors LP Bellicum Pharmaceuticals Inc [2019-08-22]
View All
Form 3/4/5 Subject 2011 - 2026
Baker Bros Advisors GP LLC
Bellicum Pharmaceuticals Inc
Baker Julian
Baker Felix
Baker Bros Advisors LP
Stonehouse Jon P
Davis Stephen
Daly James M
Huber Reid M
Klimovsky Judith V
Fair Richard A
Scripture Charity
Brown James F
Grass Charles S
Strauss David Eric
Ward Shane
Foster Aaron E
Mokari Atabak
Smith Alan K
Williams Rosemary Y
Woodard Jr Joseph Paul
Naeve Gregory S
Harrigan Edmund
Grossman William
Spencer David M
Musso Alan A
McGuyer Frank B
Moseley Ken
Slawin Kevin M
Moseley AnneMarie
Farrell Thomas J
Hoang Peter L
Senesac Joseph
McGuyer Investments Ltd
Remeditex Ventures LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Bellicum Pharmaceuticals Inc BLCM
Warrants (right to buy) · derivative
2023-11-22 Option exercise 1,941,607 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2023-11-22 Option exercise 1,941,607 $0.00
Bellicum Pharmaceuticals Inc BLCM
Warrants (right to buy) · derivative
2023-11-22 Option exercise 174,742 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2023-11-22 Option exercise 174,742 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2023-01-03 Option exercise 87,196 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2023-01-03 Option exercise 60,414 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2023-01-03 Option exercise 121,452 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2023-01-03 Option exercise 74,739 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2023-01-03 Option exercise 60,414 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2022-09-01 Option exercise 46,489 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2022-09-01 Option exercise 35,082 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2022-09-01 Option exercise 35,082 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2022-09-01 Option exercise 60,580 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2022-09-01 Option exercise 43,400 $0.00
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
2022-08-15 Grant 400,000 $1.44 576,000
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
2022-08-15 Grant 250,000 $1.44 360,000
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
2022-06-15 Grant 15,000 $0.00
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
2022-06-15 Grant 15,000 $0.00
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
2022-06-15 Grant 15,000 $0.00
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
2022-06-15 Grant 15,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com